摘要:
An epoxycyclohexenedione derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R represents C10-C25 linear or branched alkanoyl, C10-C25 linear alkenoyl or a group represented by formula (A), wherein n represents an integer of 1 to 4. This compound has antibacterial and antitumoral activities.
摘要:
A thrombocytopenia remedy containing an indolocarbazole derivative represented by general formula (I) or a pharmacologically acceptable salt thereof as the active ingredient, and a novel indolocarbazole derivative.
摘要:
A process for producing a disaccharide by conducting the condensation reaction of β-glucose-1-phosphate with a monosaccharide in an aqueous medium in the presence of an enzyme source originating in a microorganism of the genus Cattellatospora , Kineosporia , Propionibacterium or Enterococcus and having a sugar phosphorolytic activity, and harvesting the disaccharide formed in the medium. The obtained novel disaccharides are useful as medicine, food, cosmetic and enzyme stabilizer.
摘要:
Radicicol derivatives represented by general formula (I) or pharmacologically acceptable salts thereof, wherein R?1 and R2¿ may be the same or different and each represents hydrogen, alkanoyl, alkenoyl or tert-butyldimethylsilyl; and (1) when X represents halogeno, then Y represents oxygen or R?4-O-N (R4¿ being hydrogen or (un)substituted lower alkyl) and R3 represents hydrogen, alkanoyl, alkenoyl, etc.; while (2) when X is combined with R3 to represent a single bond, Y represents R?4B-O-N (R4B¿ being the same as R4). The derivatives have a tyrosine kinase inhibitory activity and thus have various pharmacological activities such as antitumor, antibacterial and immunosuppressive effects.
摘要:
An epoxycyclohexenedione derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R represents C₁₀-C₂₅ linear or branched alkanoyl, C₁₀-C₂₅ linear alkenoyl or a group represented by formula (A), wherein n represents an integer of 1 to 4. This compound has antibacterial and antitumoral activities.
摘要:
A farnesyltransferase inhibitor and an antitumor drug each containing a piperazinedione derivative represented by general formula (I) as the active ingredient, wherein R¹ and R² are the same or different from each other and each represents lower alkyl, lower alkoxyalkyl, or (un)substituted aryl or aralkyl; R³ and R⁴ are the same or different from each other and each represents mercapto, lower alkanoylthio, aroylthio, lower alkoxycarbonylthio or aryloxycarbonylthio, or R³ and R⁴ are combined with each other to represent a disulfide bond; and R⁵ and R⁶ are the same or different from each other and each represents hydrogen, lower alkyl, lower alkoxyalkyl, hydroxyalkyl, lower alkanoyloxyalkyl, aroyloxyalkyl, aralkyloxyalkyl or aralkyl.
摘要:
A saintopin E derivative represented by general formula (I) and useful as an antibacterial and antitumor agent, wherein when R¹ represents hydrogen, then R² represents SO₂OH (in the case of UCE1022), while when R¹ represents acetyl, then R² represents hydrogen (in the case of saintopin E).
摘要:
LK6-A derivatives represented by general formula (I) and pharmacologically acceptable salts thereof, which exhibit immunosuppressive, cytostatic and antitumor effects and so on, wherein R 1 is a lower alkanoyl or acryloyl group which may be substituted with, e.g., lower alkoxy, or the like; R 2 is hydrogen, halogeno or the like; R 2' is hydrogen, or R 2' together with R 3 forms a bond; R 3 is optionally substituted lower alkanoyl, or R 3 together with R 2' forms a bond; R 4 and R 5 are each hydrogen, optionally substituted lower alkanoyl or the like; R 6 is hydrogen or the like; and R 7 and R 8 are each hydrogen, optionally substituted lower alkanoyl or the like, with the proviso that LK6-A corresponding to a compound of general formula (I) where R 1 is (E)-methoxyacryloyl; R 2 , R 4 , R 5 , R 6 and R 7 are each hydrogen; R 8 is acetyl; and R 2' and R 3 together form a bond is excepted.
摘要翻译:具有通式(I)表示的LK6-A衍生物及其药理学上可接受的盐,其具有免疫抑制,细胞抑制和抗肿瘤作用等,其中R 1为低级烷酰基或丙烯酰基,其可被例如较低级 烷氧基等; R 2是氢,卤素等; R 2是氢,或R 2与R 3一起形成键; R 3是任选取代的低级烷酰基,或R 3与R 2'一起形成键; R 4和R 5各自为氢,任选取代的低级烷酰基等; R 6是氢等; R 7和R 8各自为氢,任选取代的低级烷酰基等,条件是对应于通式(I)的化合物的LK6-A,其中R 1为(E) - 甲氧基丙烯酰基 ; R 2,R 4,R 5,R 6和R 7各自为氢; R 8是乙酰基; 和R 2'和R 3一起形成键。